CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin

Experimental Cell Research
Jose A RodriguezGiuseppe Giaccone

Abstract

Survivin is a member of the inhibitor of apoptosis (IAP) family of negative regulators of programmed cell death that is frequently overexpressed in human tumors. Survivin is not only involved in the regulation of apoptosis, but is also known to play a role in the control of cell cycle progression at the G2/M phase. Survivin is a predominantly cytoplasmic protein expressed in a cell cycle-dependent manner, but the mechanism(s) that determine its nuclear-cytoplasmic localization have not been described. In this study, we report that Survivin is a nuclear shuttling protein that is actively exported from the nucleus via the CRM1-dependent pathway. Nuclear export of Survivin is independent of the export of other shuttling proteins that control the G2/M phase transition, such as cyclin B1 and cdc25. The carboxy-terminal domain of Survivin is both necessary and sufficient for its nuclear export, although this region does not contain a functional leucine-rich nuclear export signal. Differences in the amino acid sequence of this region determine the dramatically different localization of Survivin (in the cytoplasm) and its splicing variant Survivin-DeltaEx3 (in the nucleus). The carboxy-terminal end of Survivin-DeltaEx3 contains a bipar...Continue Reading

Citations

May 17, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Gou Young KimYoun Wha Kim
May 19, 2004·The Journal of Experimental Medicine·Frank AltznauerHans-Uwe Simon
Mar 26, 2003·Nucleic Acids Research·Elana MiriamiRuth Sperling
Feb 22, 2005·Journal of Theoretical Biology·Jörg W Stucki, Hans-Uwe Simon
Sep 24, 2004·Leukemia Research·Kouhei YamamotoMasanobu Kitagawa
Sep 25, 2015·Cells·Achim DickmannsRalf Ficner
May 28, 2004·Applied Immunohistochemistry & Molecular Morphology : AIMM·Barbara TringlerKenneth R Shroyer
Oct 16, 2004·World Journal of Gastroenterology : WJG·Hua MengNobuhiko Tanigawa
Jun 24, 2004·Journal of Cellular Biochemistry·Dario C Altieri
Jun 2, 2016·Journal of Cell Science·Lucia DunajováSally P Wheatley
Aug 28, 2003·Journal of Cellular Physiology·Fengzhi Li
Aug 5, 2003·The Journal of Pathology·Monica FalleniSilvano Bosari
Mar 14, 2008·American Journal of Rhinology·Zhe-Fu QiuXiang-Dong Wang
Nov 3, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B VischioniG Giaccone
May 18, 2006·Journal of Surgical Oncology·Wenji WangAiqin Wang
Jan 5, 2007·International Urology and Nephrology·Binyamini JosephJacob Ben-Chaim
Feb 24, 2005·American Journal of Hematology·Yasunori NakagawaMasanobu Kitagawa
Dec 25, 2009·Digestive Diseases and Sciences·J G KalliakmanisA Archimandritis
Jul 14, 2005·Investigational New Drugs·Kongming WuSridhar Mani
Jan 31, 2003·British Journal of Cancer·P GrabowskiH Scherübl
Jan 2, 2003·Nature Reviews. Cancer·Dario C Altieri
Oct 16, 2014·Journal of Hematology & Oncology·Kaushal ParikhDelong Liu
Dec 6, 2014·Journal of Hematology & Oncology·Giovanni Luca GravinaClaudio Festuccia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis